Mankind Pharma Limited (MANKIND.BO)
INR 2343.55
(-1.47%)
INR 2343.55
(-1.47%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -9.9 Billion INR | -636.93% |
| 2022 | -1.34 Billion INR | -123.57% |
| 2021 | 5.7 Billion INR | 676.49% |
| 2020 | 734.77 Million INR | 177.19% |
| 2019 | -951.93 Million INR | -161.88% |
| 2018 | 1.53 Billion INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 33.86 Billion INR | 441.79% |
| 2023 Q2 | -740.51 Million INR | -104.84% |
| 2023 Q1 | 15.28 Billion INR | 1236.98% |
| 2023 FY | -9.9 Billion INR | -636.93% |
| 2023 Q3 | 23.25 Billion INR | 3240.91% |
| 2023 Q4 | -9.9 Billion INR | -142.6% |
| 2022 Q4 | -1.34 Billion INR | 27.82% |
| 2022 FY | -1.34 Billion INR | -123.57% |
| 2022 Q3 | -1.86 Billion INR | 0.0% |
| 2021 Q4 | 5.7 Billion INR | 0.0% |
| 2021 FY | 5.7 Billion INR | 676.49% |
| 2020 FY | 734.77 Million INR | 177.19% |
| 2019 FY | -951.93 Million INR | -161.88% |
| 2018 FY | 1.53 Billion INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 356.292% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 368.269% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | -248.546% |
| Granules India Limited | 9.28 Billion INR | 206.689% |
| Indoco Remedies Limited | 6.47 Billion INR | 252.988% |
| Achyut Healthcare Limited | -3.74 Million INR | -264395.141% |
| Ajanta Pharma Limited | -954.9 Million INR | -937.594% |
| Alkem Laboratories Limited | -1.6 Billion INR | -515.632% |
| Alpa Laboratories Limited | 35.36 Million INR | 28117.951% |
| Brooks Laboratories Limited | 49.48 Million INR | 20122.205% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | -97.668% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 400.337% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | -755.795% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 176.729% |
| Eris Lifesciences Limited | 13.8 Billion INR | 171.764% |
| FDC Limited | -57.75 Million INR | -17056.095% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | -131.211% |
| Gufic Biosciences Limited | 3.19 Billion INR | 410.175% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | -138.571% |
| Ipca Laboratories Limited | 11.41 Billion INR | 186.796% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | -612.841% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 612.591% |
| Lasa Supergenerics Limited | 205.79 Million INR | 4914.4% |
| Laurus Labs Limited | 24.38 Billion INR | 140.632% |
| Lupin Limited | 17.19 Billion INR | 157.63% |
| Medicamen Biotech Limited | 160.31 Million INR | 6280.286% |
| Medico Remedies Limited | 78.67 Million INR | 12693.246% |
| Megasoft Limited | 1.28 Billion INR | 870.719% |
| NATCO Pharma Limited | -5.81 Billion INR | -70.328% |
| Piramal Pharma Limited | 42.27 Billion INR | 123.436% |
| RPG Life Sciences Limited | -364.7 Million INR | -2616.75% |
| Sigachi Industries Limited | 859.94 Million INR | 1252.16% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 86.328% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | 6934.226% |
| Syncom Formulations (India) Limited | 46.21 Million INR | 21540.757% |
| Unichem Laboratories Limited | 931.91 Million INR | 1163.185% |
| Wanbury Limited | 1.1 Billion INR | 995.941% |
| Windlas Biotech Limited | -273.04 Million INR | -3528.768% |
| ZIM Laboratories Limited | 983.6 Million INR | 1107.315% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 353.272% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | -952.027% |
| Divi's Laboratories Limited | -39.77 Billion INR | 75.087% |
| Hester Biosciences Limited | 2.29 Billion INR | 532.523% |
| Procter & Gamble Health Limited | -2.34 Billion INR | -321.976% |
| Amrutanjan Health Care Limited | -248.79 Million INR | -3882.438% |
| Bal Pharma Limited | 1.26 Billion INR | 884.132% |
| Strides Pharma Science Limited | 23.25 Billion INR | 142.602% |
| Venus Remedies Limited | -267.7 Million INR | -3601.154% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 479.34% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 260.914% |
| Shilpa Medicare Limited | 9.06 Billion INR | 209.245% |
| Aarti Drugs Limited | 5.54 Billion INR | 278.574% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | -799.663% |
| Suven Life Sciences Limited | -1.63 Billion INR | -506.848% |
| Ind-Swift Limited | 9.5 Billion INR | 204.2% |
| Valiant Laboratories Limited | -295.03 Million INR | -3258.276% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 451.198% |
| Solara Active Pharma Sciences Limited | 10.02 Billion INR | 198.793% |
| Themis Medicare Limited | 764.96 Million INR | 1395.226% |
| Hikal Limited | 7.96 Billion INR | 224.363% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 131.128% |
| Sequent Scientific Limited | 4.17 Billion INR | 337.111% |
| Novartis India Limited | -5.89 Billion INR | -68.186% |
| Wockhardt Limited | 18.27 Billion INR | 154.231% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 136.599% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | -53613.477% |
| Neuland Laboratories Limited | -214.05 Million INR | -4528.646% |
| Morepen Laboratories Limited | -231.17 Million INR | -4185.944% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | 8353.974% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | 1115.359% |